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Introduction
During normal conditions the kidneys regulate renal water excretion to compensate for variations in water intake and extra-renal water loss. The key hormone for regulation of renal water excretion is arginine-vasopressin (AVP), which is released from the posterior pituitary gland in response to an increase in plasma osmolality or a decrease in intravascular volume. AVP regulates water permeability of renal collecting duct (CD) principal cells by both short-and long-term regulation via the G s -coupled AVP type-2 receptor (V 2 -receptor) (Nielsen, et al., 1995; Marples, et al., 1999) . On short term, CD water permeability is increased through cAMP mediated protein kinase A (PKA) serine-256 phosphorylation of aquaporin-2 (AQP2), inducing trafficking from intracellular vesicles to the apical membrane (Deen, et al., 2000) . On long term, PKA phosphorylates and activates the cAMP responsive element binding protein to increase AQP2 gene expression (Yasui, et al., 1997) .
In response to a decrease in plasma osmolality or an increase in intravascular volume, water excretion is normally increased through a decreased AVP plasma concentration leading to AQP2 down-regulation. However, in conditions such as syndrome of inappropriate AVP release or congestive heart failure (Schrier and Martin, 1998; Feldman, et al., 2005) , a pathological over-activity of the AVP-AQP2 system leads to excessive water retention that in the end may lead to life threatening hyponatremia. For the treatment of this, it is desirable to develop compounds that increase free water clearance (i.e. produce aquaresis).
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ZP120 does not cross the blood brain barrier (Rizzi, et al., 2002) , bolus injection data suggest that i.v. nociceptin / ZP120 might have central effects on water homeostasis control (Kapusta, et al., 1997; Kapusta, et al., 2005) . We therefore wanted further data to address a possible AVP plasma concentration lowering effect by peripheral NOP stimulation. We hypothesized that an effect of i.v. ZP120 exclusively on AVP would induce an AQP2 down-regulation pattern similar to blockade of the AVP receptor.
For these purposes we investigated AQP2 protein level, mRNA level, subcellular localization and phosphorylation status, using two different infusion models. First we conducted renal clearance experiments in chronically catheterized rats in a setup where renal water losses were replaced by servo-controlled infusion of 50 mM glucose to avoid physiological antagonism (Burgess, et al., 1993) . In this model ZP120 and the V 2 -receptor antagonist OPC31260 were infused i.v. for four hours in doses that produced similar increases in fractional distal water excretion (V/C Li ). In parallel with this, we employed a one hour infusion model without volume replacement enabling investigation of AQP2 regulation during onset of aquaresis with concomitant volume loss and physiological antagonism.
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Methods
Animals. Male Wistar rats (300-400 g) (Charles River, Sulzfeld, Germany) were used for the experiments. The rats were housed in a temperature (between 22 and 24 ºC) and moisture (40-70%) controlled room with a 12 hour light-dark cycle (light on from 6:00 A.M. to 6:00 P.M.). The rats were given free access to tap water and a diet containing ~140 mmol/kg of sodium, ~275 mmol/kg potassium and 23% protein. All rat procedures followed the guidelines for the care and handling of laboratory animals established by the Danish government, and were done in accordance with the Declaration of Helsinki.
Aquaretic infusion with volume replacement. Renal function was examined in conscious chronically catheterized rats. Permanent venous, arterial and bladder catheters were implanted during anesthesia with 4% (induction) followed by 2% (maintenance) isoflurane in N 2 O/O 2 1:1. The rats were then allowed to recover for one week (to relieve post-operative pain buprenorphine (0.05 mg/kg) was administrated s.c. twice daily for two days). Two days before the experiment, the rats were switched to a diet supplemented with lithium (12 mmol/kg). The rats were accustomed to the experimental restraining cages by two sessions of training on different days. On the experimental day the rats were placed in the restraining cages and infused i.v. with a fluid containing 150 mM glucose, 6.3 mM NaCl, 2.6 mM LiCl, and tracer amounts of
JPET #123588
(32 nmol/kg/min) was started and urine was sampled in consecutive 30 min periods during the following four hours. Total body water content was kept constant during ZP120 or OPC31260 treatment by servo-controlled i.v. replacement of urine losses with 50 mM glucose (Burgess, et al., 1993; Hadrup, et al., 2004) . The mean arterial pressure was measured throughout the study and arterial blood samples (0.3 ml) were drawn every hour. The plasma concentration of AVP (Kjaer, et al., 1994) was measured in 1 ml blood samples drawn before the first control period and at the termination of the study. All blood samples were immediately replaced with heparinized blood from a donor rat (Jonassen, et al., 1998; Jonassen, et al., 2000b) . At the end of the experiment the rats were anaesthetized with 4% (induction) followed by 2% (maintenance) isoflurane in N 2 O/O 2 1:1. The right kidney was removed and divided into 1) cortex/outer stripe of outer medulla (Ctx/OSOM), 2) inner stripe of outer medulla (ISOM) and 3) inner medulla (IM). The kidney zones were frozen in liquid nitrogen and stored at -80 °C until processing for AQP2 mRNA and protein level measurements. The weight proportions of these zones were Ctx/OSOM: 79±2%, ISOM: 19±2%, and IM: 3±0.2% (mean ± SD, n=6). The left kidney was in situ perfused as described below, and the rats were euthanized.
Free water clearance. (C H2O ) was calculated as urine volume (V) -osmolar clearance (C osm ) in which C osm = V * U osm /P osm (U osm = urine osmolarity; P osm = plasma osmolarity). Lithium clearance (C Li ) was used as a marker for the output of isotonic fluid from the proximal tubules (Thomsen and Shirley, 1997 is calculated as: C Na /C Li . In which: can = (V * U Na ) / P Na , (U Na = urine sodium concentration; P Na = plasma sodium concentration).
Aquaretic infusion without volume replacement. Permanent venous catheters were implanted during anesthesia with 4% (induction) followed by 2% (maintenance) isoflurane in N 2 O/O 2 1:1. One week later the rats were accustomed to the experimental restraining cages by two sessions of training. On the day of the experiment, the animals were randomized and placed in restraining cages. After one hour of vehicle infusion (150 mM NaCl, 0.5 ml/hour) the animals were infused i.v. with 0.5 ml/hour ZP120 (1 nmol/kg/min), OPC31260 (32 nmol/kg/min) or vehicle for one hour. Then the rats were anaesthetized by i.v. injection of pentobarbitone (40 mg/kg), the kidneys were rapidly removed and divided into: Ctx/OSOM, ISOM and IM. The kidney zones were frozen in liquid nitrogen and stored at -80 °C until processing for Western blotting and mRNA measurement.
AQP2 protein level measurement. Kidney zones were homogenized in buffer containing 300 mM sucrose, 25 mM imidazole, 1 mM EDTA, 0.1 mg/ml pefabloc, 4 µg/ml leupeptin, 184 µg/ml sodium ortho-vanadate, 1 mg/ml sodium fluoride and 82 µg/ml okadeic acid (Sigma, St Louis, USA). The protein concentration was assessed with
Pierce BCA (Pierce Biotechnology, Rockford, IL, USA) and adjusted to the same level.
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Results
Infusion of ZP120 (1 nmol/kg/min) or OPC31260 (32 nmol/kg/min) with replacement of urinary volume losses produced, as previously shown (Hadrup, et al., 2004; Jonassen, et al., 2000b; Jonassen, et al., 2000a) , marked increases in diuresis (ZP120 ∆ µl/min/100 g b.w., ± SD) (Fig.1B) . The fractional distal water excretion can be estimated from the ratio between the diuresis and the lithium clearance (V/C Li ). Both OPC31260
and ZP120 increased V/C Li to ~40% (OPC31260: 40.4 ± 7.0% and ZP120: 39.2 ± 9.0%, mean ± SD) showing that V 2 -receptor blockade and NOP stimulation produced a comparable blockade on distal water reabsorption (Fig. 1C) . MAP was unchanged in all groups throughout the study (table 1) . In contrast to previous studies conducted with the same setup (Hadrup, et al., 2004; Jonassen, et al., 2000b; Jonassen, et al., 2000a) , ZP120
and OPC31260 infusion coincided with a reduction in GFR (table 1) . We note that although no protocol or equipment abnormalities were detected and steady state diuresis was obtained, minute volume depletion could explain the GFR effects. FE Li was not different when comparing ZP120 with control rats. However, we measured a significant difference when comparing OPC31260 (24±9%, mean last 1½ hours, ± SD, Table 1 ) with ZP120 (16±3%) or control (17±4%) indicating that the fractional proximal sodium reabsorption was decreased by OPC31260. In regard to U Na V, C Na and FE Na distal , ZP120
displayed antinatriuresis when compared with control and OPC31260 (Fig. 2) . Neither
This article has not been copyedited and formatted. The final version may differ from this version. OPC31260 nor ZP120 treatment induced significant changes in the circulating concentrations of AVP (Table 1) , and in line with previously reported data (Hadrup, et al., 2004) , we found no correlation between changes in diuresis and changes in the AVP plasma concentration (correlation coefficients, ZP120: -0.06, n.s.; OPC31260: -0.5, n.s.).
We have previously shown that ZP120 induced aquaresis is associated with a decreased AQP2 protein level in whole kidney preparations. In the present study we investigated the zonal localization of this down-regulation in comparison with the V 2 -receptor antagonist OPC31260. ZP120 induced steady state aquaresis in the volume replacement model was associated with a decreased AQP2 protein level in the Ctx/OSOM, and an unchanged level in the ISOM and the IM (Fig. 3A) . The downregulation of AQP2 in the Ctx/OSOM was also present after one hour of infusion without volume replacement. The AQP2 protein level was unchanged in the ISOM, whereas the AQP2 protein level within the IM was increased without volume replacement (Fig. 4A ).
There were no differences in the effects of ZP120C on glycosylated and non-glycosylated AQP2 in the Ctx/OSOM, respectively (statistics not included). In the steady state animal model with volume replacement, OPC31260 induced aquaresis was associated with a down-regulated AQP2 protein level in both the Ctx/OSOM and ISOM, and an unchanged level in the IM (Fig. 3B) . In contrast, OPC31260 infusion in the one hour model without volume replacement was associated with a slight up-regulation of the AQP2 protein level in the Ctx/OSOM (Fig. 4B ).
Water is reabsorbed across the CD epithelium only when AQP2 is located in the apical principal cell membrane. We investigated whether ZP120 and OPC31260 induced aquaresis was associated with a decreased apical localization of AQP2 in different kidney 5 ). ZP120 displayed no significant decrease in apical AQP2 localization in the OM (P=0.24), whereas there was a strong tendency to decreased apical labeling in the IM (P=0.06). In regard to serine-256 phosphorylated AQP2, the P values for decreased apical labeling were Ctx: 0.24; OM 1.0 and IM: 0.24 (pictures not shown). OPC31260
induced aquaresis was associated with a significantly decreased apical labeling in Ctx (P=0.002) and OM (P=0.002), whereas decreased apical labeling was only nearsignificant in the IM (P=0.08) (Fig. 5) . In regard to serine-256 phosphorylation, there were significant decreases in apical labeling by OPC31260 in all kidney zones (pictures not shown).
We investigated whether the decreased AQP2 protein levels in the CD´s of ZP120 and OPC31260 infused rats were associated with a decreased AQP2 mRNA level, which would suggest that down-regulation happened through decreased production rather than increased degradation. We established a real-time PCR method using specific AQP2 primers and a specific AQP2 TaqMan probe to measure the AQP2 mRNA level. We confirmed the method by showing that we could measure an increased AQP2 mRNA level in water deprived rats compared with water loaded rats (Fig. 6A ). ZP120 induced diuresis was not associated with down-regulation of the AQP2 mRNA level in any of the kidney zones (Fig. 6B, C ). Actually the AQP2 mRNA level was up-regulated in the outer medulla after infusion of ZP120 for one hour without volume replacement. With OPC31260 no changes were found in the Ctx/OSOM and ISOM; whereas a significant This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
The fact that we solely found ZP120 induced decreases in AQP2 protein level in the Ctx/OSOM is consistent with previous results showing down-regulation when measured in whole kidney homogenates (Hadrup, et al., 2004) . The Ctx/OSOM constitutes 80% of the rat kidney, and in addition to CD's, AQP2 is also expressed in connecting tubules in the Ctx. Moreover, the down-regulation was seen both with and without volume replacement, suggesting a persistent effect not counteracted by volume loss. A decreased protein level means lower availability of water channels for osmotic water reabsorption.
However, substantial water reabsorption through AQP2 in the apical membrane may still occur if remaining water channels are being targeted to this site. Therefore we investigated apical AQP2 localization by immunohistochemistry. We found that the AQP2 protein down-regulation was accompanied by a decreased apical AQP2 localization in the Ctx indicating that the remaining AQP2 is not involved in such sustained water reabsorption. There was also a strong tendency to a decreased apical AQP2 labeling by ZP120 in the IM. However, in this zone the AQP2 level was not decreased accordingly and was even up-regulated when ZP120 was infused without volume replacement. This suggests that in the IM a decreased protein level is not a prerequisite to decreased water reabsorption, which is then solely mediated by retrieval of AQP2 from the membrane.
We then addressed whether the mechanism underlying the decreased AQP2 protein level in the Ctx/OSOM involved decreased production or increased degradation. We measured mRNA to determine whether this regulated step in production was downregulated. However, we did not find the AQP2 mRNA level to be decreased upon ZP120
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In the ISOM there was no effect of ZP120 in regard to decreases in protein level or apical localization, suggesting that this zone is not involved in the aquaretic effect of this compound.
Effects of V 2 -receptor antagonism on AQP2 regulation have been extensively investigated in the IM; and our results on this zone are in line with those previously reported by others (Christensen, et al., 1998; Hayashi, et al., 1994; Marples, et al., 1998) .
In regard to the Ctx and OM, it has been reported that AQP2 was diffusely stained in CD by V 2 -receptor antagonism following OPC31260 infusion (Hayashi M, et al., 1996) .
Echevarria et al found no effect of V 2 -receptor antagonism when investigating mRNA level in Ctx and medulla in water deprived rats with increased plasma concentrations of AVP (Murillo-Carretero, et al., 1999) . In rats with experimentally induced congestive heart failure and increased plasma AVP plasma concentration, Xu and coworkers showed a decreased mRNA level in Ctx, and decreased AQP2 protein level in the Ctx membrane fraction (Xu, et al., 1997) . In the present study we employed a volume replacement model to investigate AQP2 down-regulation during steady state diuresis induced by V 2 -receptor antagonism. We found a decreased AQP2 protein level in both the Ctx/OSOM and ISOM. The apical labeling of AQP2 was down-regulated throughout the Ctx and OM and to a strong extent IM. In addition, supporting these data, serine-256 phosphorylated AQP2 was significantly down-regulated throughout all kidney zones by OPC31260 (data not shown). In contrast to rats receiving volume replacement, and in contrast to infusion with ZP120, we did not find a decreased AQP2 protein level in animals infused with This article has not been copyedited and formatted. The final version may differ from this version. (Marples, et al., 1998) .
This finding suggests that a decrease in AQP2 mRNA level does not rapidly result in a decreased protein level, perhaps due to low AQP2 turnover in this zone.
We previously mapped NOP in the CD by immunohistochemistry and Western blotting and found it in intercalated cells in the Ctx and OM and in regard to principal cells only in the IM (Hadrup, et al., 2004) . This causes a discrepancy between the AQP2 down-regulation pattern and the NOP expression pattern in regard to the Ctx/OSOM, because AQP2 is only found in principal cells. Speculative explanations for this are: In regard to sodium handling, ZP120 displays an antinatriuretic effect compared to control and OPC31260 (Fig. 2) . To determine tubular localization of this effect, we measured sodium handling in the proximal (FE Li ) and distal tubules (FE Na distal ). We found that the proximal sodium excretion was different between the two compounds.
This difference was mediated through a slight increase by OPC31260 combined with a slight decrease by ZP120. However, only OPC3160 was significantly different from the control group, indicating that this compound by increasing fractional proximal excretion was responsible for the difference. ZP120 decreased FE NA distal indicating that the antinatriuretic effect of this compound was mediated via the distal part of the nephron or in the CD.
It makes sense that the antinatriuretic effect of NOP stimulation is comprised of combined sodium and water channel regulation in the distal tubules. When sodium reabsorption is increased by NOP stimulation, there will be an increased osmotic driving force for water reabsorption through AQP2 localized in the apical membrane. Therefore unless AQP2 is down-regulated, the antinatriuretic effect would potentially be converted into a combined sodium and water retaining effect. The fact that AQP2 is down-regulated in the Ctx/OSOM indicates involvement of sodium transporters such as the Na + /Cl --co-transporter and/or the epithelial sodium channel both located in this zone. It is noticeable that the endogenous V 2 -receptor ligand AVP and the endogenous NOP ligand nociceptin only counteract each other in regard to water homeostasis. In relation to sodium homeostasis both ligands increase reabsorption. AVP has been described to increase Na + -K + -2Cl --co-transporter and epithelial sodium channel protein levels (Ecelbarger, et al., 2001; Gimenez and Forbush, 2003) .
From a pharmacological point of view ZP120 and OPC31260 have somewhat different profiles. The slightly larger aquaresis produced by OPC31260 in comparison with ZP120 ( fig 1B) could be attributed to an effect on all three kidney zones compared to the more selective effect of ZP120. This indicates that OPC31260, at the dose used (32 nmol/kg/min), has a stronger aquaretic effect than ZP120 (1 nmol/kg/min). However, in contrast to OPC31260, the effect of ZP120 on AQP2 protein level down-regulation was not masked by volume loss in the one hour infusion model suggesting an effect of ZP120 more persistent to physiological antagonism. Moreover, for potential treatment of hyponatremia, the antinatriuretic of ZP120 may be an advantage, to quickly restore the sodium plasma concentration.
We conclude that equi-aquaretic doses of the peripherally acting NOP agonist, ZP120, and the selective AVP type-2 receptor antagonist, OPC31260, produce differential renal regional effects on AQP2 down-regulation, suggesting that these compounds employ different signaling pathways. Future investigations on NOP mediated renal effects should be focused at the Ctx/OSOM and the IM, whereas V 2 -receptor antagonism acts in all kidney zones.
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